<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37647424</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2050-4527</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Immunity, inflammation and disease</Title><ISOAbbreviation>Immun Inflamm Dis</ISOAbbreviation></Journal><ArticleTitle>Targetoid-like lesions and chilblain-like erythema manifested on hands and feet: A case of Rowell syndrome from China.</ArticleTitle><Pagination><StartPage>e979</StartPage><MedlinePgn>e979</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e979</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/iid3.979</ELocationID><Abstract><AbstractText Label="BACKGROUND">Rowell syndrome (RS) is an uncommon condition characterized by erythema multiforme (EM)-like lesions and lupus erythematosus. It is more common in females, and EM may be the first manifestation of the disease with positive autoantibodies, such as antinuclear antibody (ANA), SSA, SSB and rheumatoid factor. The pathogenesis of RS is unknown and is likely caused by drug induction, ultraviolet exposure and infection.</AbstractText><AbstractText Label="METHOD">We describe a case of RS from China which presented as characteristic targetoid-like lesions and chilblain-like erythema on hands and feet. This is a case of RS in a female patient from the inpatient department of dermatology.</AbstractText><AbstractText Label="RESULTS">A 41-year-old female with systemic lupus erythematosus&#xa0;exhibited chilblain-like erythema and characteristic EM lesions on her extremities. She tested positive for serum ANA&#xa0;(1:320) and anti-double-stranded DNA, as well as other autoantibodies. Systemic glucocorticoids and hydroxychloroquine worked effectively for her.</AbstractText><AbstractText Label="CONCLUSION">The present case met diagnostic criteria of RS. Notably, there was a co-occurrence of facial butterfly erythema, chilblain-like erythema and EM lesions distributed on the limbs in this case.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanqiao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1258-7676</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Shi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Chuanpeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guangxing</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xuejun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immun Inflamm Dis</MedlineTA><NlmUniqueID>101635460</NlmUniqueID><ISSNLinking>2050-4527</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002647" MajorTopicYN="Y">Chilblains</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004890" MajorTopicYN="N">Erythema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Rowell syndrome</Keyword><Keyword MajorTopicYN="N">erythema multiforme</Keyword><Keyword MajorTopicYN="N">lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>14</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37647424</ArticleId><ArticleId IdType="pmc">PMC10461425</ArticleId><ArticleId IdType="doi">10.1002/iid3.979</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowell NR. Lupus erythematosus and erythema multiforme&#x2010;like lesions: a syndrome with characteristic immunological abnormalities. Arch Dermatol. 1963;88:176&#x2010;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">14043605</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeitouni NC, Funaro D, Cloutier RA, Gagn&#xe9; E, Claveau J. Redefining Rowell's syndrome. Br J Dermatol. 2000;142:343&#x2010;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">10730772</ArticleId></ArticleIdList></Reference><Reference><Citation>Child F, Kapur N, Creamer D, Kobza Black A. Rowell's syndrome: Rowell's syndrome. Clin Exp Dermatol. 1999;24:74&#x2010;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">10233657</ArticleId></ArticleIdList></Reference><Reference><Citation>Drenovska K, Shahid M, Mateeva V, Vassileva S. Case report: Rowell syndrome&#x2013;like flare of cutaneous lupus erythematosus following COVID&#x2010;19 infection. Front Med. 2022;9:815743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882728</ArticleId><ArticleId IdType="pubmed">35237629</ArticleId></ArticleIdList></Reference><Reference><Citation>Shope C, Andrews L, Cunningham M, Connett J. A case of Rowell syndrome with excellent improvement following anifrolumab. JAAD Case Rep. 2023;31:27&#x2010;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9720243</ArticleId><ArticleId IdType="pubmed">36478979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W, Ma Y, Wang P, Xu A&#x2010;e. A case of rowell syndrome manifested on hands: targetoid&#x2010;like lesions and nailfold capillaries. J Rheumatol. 2022;49:jrheum.220252.</Citation><ArticleIdList><ArticleId IdType="pubmed">35777818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward JM, Hess JN, Davis LS. Targetoid&#x2010;like lesions in the setting of systemic lupus erythematosus: a case of rowell syndrome. J Rheumatol. 2020;47:298&#x2010;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">32007943</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman EE, Mcmahon DE, Lipoff JB, et al. The spectrum of COVID&#x2010;19&#x2010;associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83:1118&#x2010;1129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331510</ArticleId><ArticleId IdType="pubmed">32622888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeitouni NC, Funaro D, Cloutier RA, Gagn&#xe9; E, Claveau J. Redefining Rowell's syndrome. Br J Dermatol. 2000;142:343&#x2010;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">10730772</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Lu J, Zhang B, Li Z, Wu W. Rowell's syndrome with lupus hepatitis: a case report from China. Indian J Dermatol. 2020;65:549&#x2010;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810084</ArticleId><ArticleId IdType="pubmed">33487724</ArticleId></ArticleIdList></Reference><Reference><Citation>Millard L, Rowell N. Chilblain lupus erythematosus (Hutchinson) a clinical and laboratory study of 17 patients. Br J Dermatol. 1978;98:497&#x2010;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">656324</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi GM, Shen A, Mazloom A, et al. Lupus erythematosus masquerading as erythema multiforme: does Rowell syndrome really exist? Dermatol Online J. 2009;15. 10.5070/D39q89x24r</Citation><ArticleIdList><ArticleId IdType="doi">10.5070/D39q89x24r</ArticleId><ArticleId IdType="pubmed">19336022</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandpur S, Das S, Singh MK. Rowell's syndrome revisited: report of two cases from India. Int J Dermatol. 2005;44:545&#x2010;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">15985021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Schloss E, Kowichi J. Rowell's syndrome: a case report with subacute cutaneous lupus erythematosus and erythema multiforme. Can J Dermatol. 1995;7:807&#x2010;810.</Citation></Reference><Reference><Citation>Challa M, Baisya R, Devarasetti PK. Rowell syndrome with good response to methotrexate. Mediterranean J&#xa0;Rheumatol. 2022;33:92&#x2010;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9092095</ArticleId><ArticleId IdType="pubmed">35611104</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat R, Varma C, Bhatt S, Balachandran C. Rowell syndrome. Indian Dermatol Online J. 2014;5:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4252948</ArticleId><ArticleId IdType="pubmed">25506561</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller CSL, Hinterberger LR, Vogt T. Successful treatment of Rowell syndrome using oral cyclosporine A. Int J Dermatol. 2011;50:1020&#x2010;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">21781081</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang X, Ren L, Sun G, et al. Anti&#x2010;dsDNA, anti&#x2010;nucleosome, anti&#x2010;C1q, and anti&#x2010;histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity. Immun Inflamm Dis. 2021;9:407&#x2010;418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8127563</ArticleId><ArticleId IdType="pubmed">33470559</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>